MedPath

Diffuse Brainstem Glioma Tumour Study: developing new treatment strategies for Diffuse Pontine Glioma

Not Applicable
Recruiting
Conditions
Diffuse Pontine Glioma
Diffuse Midline Glioma
High grade glioma
Cancer - Brain
Registration Number
ACTRN12612001183875
Lead Sponsor
Dr. David Ziegler
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
36
Inclusion Criteria

1. Patients of any age with clinical and radiological diagnosis of diffuse brainstem glioma
OR
2. Patients with diffuse midline gliomas not involving the brainstem
OR
3. Patients with high grade gliomas in other locations
4. Patients with other histologies may be included only after discussion with the study chair

Exclusion Criteria

1. Patients with low grade gliomas

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
develop new treatment strategies for diffuse pontine glioma by culturing cells from autopsy specimens in vivo and identifying cells/molecules that inhibit the propagation of diffuse pontine glioma[ at the end of study];harvest diffuse pontine glioma specimens, grow viable stem cells and culture new cell lines[ at the end of the study]
Secondary Outcome Measures
NameTimeMethod
il[ Nil]
© Copyright 2025. All Rights Reserved by MedPath